论文部分内容阅读
目的探讨肝动脉化疗栓塞(TACE)联合射频消融(RFA)治疗肝转移瘤的临床疗效。方法选取不能行手术切除的肝转移瘤35例,经肝TACE联合RFA治疗,观察近期疗效及6、12、18个月的生存率。结果 35例肝转移瘤共154个病灶行49次肝TACE及42次RFA,病灶的完全坏死率为85.7%(30/35),全部病例6、12、18个月生存率分别为100%、94.3%、88.6%。结论 TACE联合RFA治疗肝转移瘤是一种有效的微创治疗方法。
Objective To investigate the clinical efficacy of hepatic arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) in the treatment of liver metastases. Methods Thirty-five cases of hepatic metastases that could not be surgically resected were treated with TACE combined with RFA. The short-term efficacy and survival rates at 6, 12, and 18 months were observed. Results A total of 154 lesions of liver metastases were performed in 49 patients with liver TACE and 42 RFA. The complete necrosis rate of the lesions was 85.7% (30/35). The overall survival rates at 6, 12, and 18 months were 100%. 94.3%, 88.6%. Conclusion TACE combined with RFA is an effective minimally invasive treatment for liver metastases.